You see the disease advancing and you know there is no cure
Since 1872, Huntington's disease has occupied a quiet but devastating corner of human medicine — a genetic sentence written into a single chromosome, unfolding across decades with no cure in sight. In Argentina, thousands live with this inheritance, among them Francisco Javier, a 36-year-old former national swimming champion who carries the mutation and continues to move through life with remarkable intention. His story, and that of his family, reflects the broader human condition of living meaningfully within limits we did not choose. Science is beginning to find its footing, but for now, love and community remain the most reliable medicine.
- A single chromosomal mutation — when a nucleotide triplet repeats more than 40 times — guarantees neurological deterioration, leaving carriers and their families in a state of anticipatory grief with no curative exit.
- In Entre Ríos alone, more than 40 confirmed cases at a single hospital suggest the disease is far more prevalent than official statistics acknowledge, straining families and healthcare systems alike.
- Symptoms arrive in waves — first as anxiety and depression, then as involuntary movements the body cannot suppress, and finally as cognitive erosion that traps the person within themselves.
- Experimental drugs targeting the defective protein at its source are advancing through early trials, offering the first real directional hope after more than 150 years of purely symptomatic treatment.
- Francisco's family and community have built a living counter-force to isolation — bus drivers, theater colleagues, and caregivers choosing dignity over pity, demonstrating that social resilience can coexist with medical helplessness.
Huntington's disease has been known to medicine since 1872, yet more than a century and a half later it remains without a cure. Caused by a mutation on a single chromosome — a nucleotide triplet that, when repeated more than 40 times, guarantees the disease will manifest — it dismantles nerve cells over decades, stripping away movement, mood, and memory. In Argentina, 8 to 10 people per 100,000 carry the diagnosis, though in Entre Ríos the numbers run higher: Hospital Baxada in Paraná alone has recorded more than 40 positive cases. The inheritance is unsparing — dominant, with a 50 percent chance of transmission to each child.
Francisco Javier is 36 years old and carries the mutation. He was once a competitive swimmer who claimed nine consecutive Argentine national championships. Today he still navigates daily life with striking autonomy — managing his affairs, attending the theater, moving through his community with purpose. His parents, Gloria and Alfredo, have watched both his vitality and his diagnosis with the particular anguish of those who love someone the disease has already claimed on paper, even as the person before them remains fully present.
Symptoms tend to emerge first as psychiatric disturbance — anxiety, depression — before giving way to the involuntary movements known as chorea, and eventually to cognitive decline. There is no treatment that halts this progression. Doctors manage what appears: medications for mood, rehabilitation to preserve function, and for those still asymptomatic, a regimen of physical activity and mental stimulation that may slow but cannot stop the disease's advance.
Yet the horizon is not entirely dark. Researchers are developing experimental drugs designed to block the defective protein before it forms — an approach that, if successful, would represent the first true intervention in the disease's mechanism. Trials remain early, and no breakthrough has arrived. But the direction of the science has shifted.
Alfredo speaks plainly about the weight his family carries, watching the disease advance without recourse. Gloria finds sustenance in visibility — in refusing silence, in believing that a difficult path can still be walked with love. Around Francisco, a community has quietly organized itself: neighbors, colleagues, strangers who choose to meet him with warmth rather than pity. In a disease that tends to isolate, that human network has become, for now, the most powerful medicine available.
Huntington's disease arrived in medical literature in 1872, named for the physician who first described it. Today, more than 150 years later, it remains incurable—a genetic disorder that unfolds across decades, stealing movement and mind from those who carry its mutation. In Argentina, between 8 and 10 people per 100,000 inhabitants live with the diagnosis. In the province of Entre Ríos, the numbers are higher. At Hospital Baxada in Paraná alone, more than 40 patients have tested positive, suggesting the true prevalence runs deeper than official counts.
The disease begins at the molecular level, in a single chromosome where a triplet of nucleotides carries corrupted information. Everyone carries this sequence, but when it repeats more than 40 times, the outcome becomes certain: the disease will manifest. Neurologist Javier Role explained the mechanism with precision. The mutation disrupts a protein essential to nerve cells. Over time, those cells die. The inheritance pattern is unforgiving—dominant, meaning a parent with the mutation has a 50 percent chance of passing it to each child, regardless of the child's sex.
Francisco Javier is 36 years old. He carries the mutation. His parents, Gloria and Alfredo, watched him grow into a man of uncommon vitality—a physical education teacher, a competitive swimmer who won nine consecutive Argentine national championships. He still moves through the world with purpose: he goes to the bank, handles his affairs, attends theater performances with the devotion of someone who has found refuge in art. Yet the disease is present in his body, advancing according to its own timeline.
Symptoms do not announce themselves uniformly. Some patients carry the genetic alteration for years without noticing anything wrong. When symptoms do emerge, they often arrive first as psychiatric disturbance—anxiety, depression, a darkening of mood that precedes the physical signs. Then come the involuntary movements, the characteristic jerking that doctors call chorea, as if the body were dancing against its own will. Finally, cognition deteriorates. Memory fragments. Thought becomes difficult. The person remains, but increasingly trapped.
There is no cure. Treatment today is symptomatic, meaning doctors address what appears: psychiatric medications for mood disorders, interventions for movement problems, rehabilitation to preserve function as long as possible. For those who have not yet shown symptoms but carry the mutation, the prescription is preventive—sustained physical activity, good nutrition, constant mental stimulation. These cannot stop the disease, but they may slow it.
Hope, however tentative, is emerging from research laboratories. For several years, scientists have been developing experimental drugs designed to prevent the defective protein from forming in the first place. These trials remain in early stages. No breakthrough has arrived. But the direction of the work suggests that the long silence around Huntington's—the decades when nothing could be done—may eventually end.
Alfredo speaks of the weight his family carries. "You see the disease advancing and you know there is no cure," he said. Yet he also speaks of his son's resilience, the force of will that keeps Francisco engaged with life despite the diagnosis. Gloria adds another dimension: visibility, she believes, sustains hope. "It is a difficult path, but it can be walked with love." Around Francisco moves a network of professionals and ordinary people—bus drivers who greet him, theater colleagues who welcome him, a community that has chosen to treat him with respect and affection rather than pity. In a disease that isolates, that network becomes everything.
Notable Quotes
You see the disease advancing and you know there is no cure, but Francisco is a very special young man who lives happily with admirable strength and will— Alfredo, Francisco's father
The idea is to make this visible so people don't lose faith, because although it is a difficult path, it can be walked with love— Gloria, Francisco's mother
The Hearth Conversation Another angle on the story
Why does Huntington's appear more often in Entre Ríos than elsewhere in Argentina?
No one knows for certain. It could be genetic drift—a founder effect, where an ancestor carried the mutation and passed it through generations in a concentrated region. Or it could simply be that doctors there are better at recognizing it, testing for it. The disease is rare enough that many cases go undiagnosed.
If Francisco's parents didn't have Huntington's, how did he inherit it?
One of them must carry the mutation, even if they haven't shown symptoms yet. The disease can remain silent for decades. A parent might be asymptomatic their entire life and still pass the mutation to their children. Francisco's case suggests one parent is a carrier.
You mentioned experimental drugs. How close are we to something that actually works?
We're in early stages. The science is sound—if you can prevent the defective protein from forming, you might prevent the disease from progressing. But "early stages" means years away from knowing if it works in humans, if it's safe, if it changes the outcome. Hope is not the same as certainty.
What's the cruelest part of this disease?
The waiting. Some people know they carry the mutation and spend decades wondering when symptoms will arrive. Others watch a parent deteriorate and calculate their own odds. And once symptoms begin, there's no reversal. You only move forward into greater loss.
How does Francisco stay so engaged with life?
That's a question only he can fully answer. But his parents suggest it's partly temperament—he's always been someone who finds meaning in activity, in teaching, in art. And partly it's the people around him who refuse to treat him as already gone. That matters more than people realize.